As of 2025-11-05, the Relative Valuation of Bolt Biotherapeutics Inc (BOLT) is (248.28) USD. This relative valuation is based on P/E multiples. With the latest stock price at 5.04 USD, the upside of Bolt Biotherapeutics Inc based on Relative Valuation is -5026.2%.
The range of the Relative Valuation is (153.20) - (305.33) USD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 5.8x - 11.6x | 9.4x |
| Forward P/E multiples | 5.8x - 11.6x | 9.4x |
| Fair Price | (153.20) - (305.33) | (248.28) |
| Upside | -3139.6% - -6158.2% | -5026.2% |
| Date | P/E |
| 2025-11-03 | -0.21 |
| 2025-10-31 | -0.22 |
| 2025-10-30 | -0.22 |
| 2025-10-29 | -0.22 |
| 2025-10-28 | -0.22 |
| 2025-10-27 | -0.24 |
| 2025-10-24 | -0.23 |
| 2025-10-23 | -0.22 |
| 2025-10-22 | -0.21 |
| 2025-10-21 | -0.22 |
| 2025-10-20 | -0.22 |
| 2025-10-17 | -0.22 |
| 2025-10-16 | -0.22 |
| 2025-10-15 | -0.23 |
| 2025-10-14 | -0.22 |
| 2025-10-13 | -0.22 |
| 2025-10-10 | -0.22 |
| 2025-10-09 | -0.22 |
| 2025-10-08 | -0.24 |
| 2025-10-07 | -0.23 |
| 2025-10-06 | -0.20 |
| 2025-10-03 | -0.20 |
| 2025-10-02 | -0.19 |
| 2025-10-01 | -0.21 |
| 2025-09-30 | -0.20 |
| 2025-09-29 | -0.20 |
| 2025-09-26 | -0.21 |
| 2025-09-25 | -0.21 |
| 2025-09-24 | -0.22 |
| 2025-09-23 | -0.21 |
| 2025-09-22 | -0.20 |
| 2025-09-19 | -0.20 |
| 2025-09-18 | -0.20 |
| 2025-09-17 | -0.20 |
| 2025-09-16 | -0.19 |
| 2025-09-15 | -0.20 |
| 2025-09-12 | -0.20 |
| 2025-09-11 | -0.20 |
| 2025-09-10 | -0.20 |
| 2025-09-09 | -0.19 |
| 2025-09-08 | -0.19 |
| 2025-09-05 | -0.20 |
| 2025-09-04 | -0.18 |
| 2025-09-03 | -0.18 |
| 2025-09-02 | -0.19 |
| 2025-08-29 | -0.19 |
| 2025-08-28 | -0.20 |
| 2025-08-27 | -0.20 |
| 2025-08-26 | -0.20 |
| 2025-08-25 | -0.21 |